In 2012, the Food and Drug Administration (FDA) conducted inspections of two Sanofi Pasteur vaccine production facilities. This 10-page letter from the FDA to Sanofi’s Senior Vice President of Vaccines, describes the significant objectionable conditions and deviations observed at each of the facilities.